Olivier Belenger Net Worth

The estimated Net Worth of Olivier Belenger is at least $4.9 Milion dollars as of 11 October 2017. Olivier Belenger owns over 5,000,000 units of Orgenesis Inc stock worth over $3,649,114 and over the last 7 years Olivier sold ORGS stock worth over $1,250,000.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Olivier Belenger ORGS stock SEC Form 4 insiders trading

Olivier has made over 1 trades of the Orgenesis Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Olivier sold 5,000,000 units of ORGS stock worth $1,250,000 on 11 October 2017.

The largest trade Olivier's ever made was selling 5,000,000 units of Orgenesis Inc stock on 11 October 2017 worth over $1,250,000. On average, Olivier trades about 5,000,000 units every 0 days since 2017. As of 11 October 2017 Olivier still owns at least 5,904,716 units of Orgenesis Inc stock.

You can see the complete history of Olivier Belenger stock trades at the bottom of the page.

What's Olivier Belenger's mailing address?

Olivier's mailing address filed with the SEC is ALLEE DE LA RECHERCHE, 12, , ANDERLECHT, C9, 1070.

Insiders trading at Orgenesis Inc

Over the last 12 years, insiders at Orgenesis Inc have traded over $4,872,134 worth of Orgenesis Inc stock and bought 375,420 units worth $216,187 . The most active insiders traders include Sca Theodorus, Ii Sa Theodorus oraz Olivier Belenger. On average, Orgenesis Inc executives and independent directors trade stock every 263 days with the average trade being worth of $1,118,704. The most recent stock trade was executed by Victor Miller on 1 April 2024, trading 25,000 units of ORGS stock currently worth $12,500.

What does Orgenesis Inc do?

orgenesis inc (orgs) is a medical device company located in 21 sparrow cir, white plains, new york, united states.

Complete history of Olivier Belenger stock trades at Orgenesis Inc

Orgenesis Inc executives and stock owners

Orgenesis Inc executives and other stock owners filed with the SEC include:

• Vered Caplan,
  Chairperson of the Board of Directors, Chief Executive Officer
• Vered Caplan M.Sc.,
  Chairperson of the Board, CEO & Pres
• Darren Head,
  Chief Executive Officer of Masthercell Global
• Neil T. Reithinger CPA,
  CFO, Sec. & Treasurer
• Denis Bedoret,
  President of Masthercell Global
• Sarah Ferber,
  Chief Scientific Officer
• Neil Reithinger,
  Chief Financial Officer, Treasurer, Secretary
• David Sidransky,
  Independent Director
• Guy Yachin,
  Independent Director
• Yaron Adler,
  Independent Director
• Ashish Nanda,
  Independent Director
• Mario Philips,
  Independent Director
• Vincent Vandamme,
  Sr. VP of Quality Strategy
• Lilach Harel,
  VP of Global HR
• Osher Partok Rheinisch,
  Gen. Counsel & Compliance Officer
• Dr. Shimon Hassin Ph.D.,
  Chief Technology Officer
• Joseph Green,
  Chief Operating Officer
• Evan Fishman,
  Chief Financial Officer
• Prof. Sarah Ferber Ph.D.,
  Founder & Chief Scientific Officer
• Elliot Maltz,
  Chief Financial Officer
• Olivier Belenger,
  
• Hugues Bultot,
  Director
• Libre De Bruxelles Universite,
  
• Ii Sa Theodorus,
  
• Sca Theodorus,
  
• Etti Hanochi,
  Director
• Itzhak Vider,
  Director
• Victor Miller,
  CHIEF FINANCIAL OFFICER
• Jacob Safier,
  10% owner
• Mark Goodman,
  Director
• Kunik Efrat Assa,
  Chief Development Officer